Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · IEX Real-Time Price · USD
21.82
-0.20 (-0.91%)
At close: Jul 19, 2024, 4:00 PM
21.86
+0.04 (0.18%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Fulgent Genetics Revenue

Fulgent Genetics had revenue of $287.53M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $64.49M. In the year 2023, Fulgent Genetics had annual revenue of $289.21M.

Revenue (ttm)
$287.53M
Revenue Growth
-21.20%
P/S Ratio
2.27
Revenue / Employee
$242,846
Employees
1,184
Market Cap
652.95M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023289.21M-329.76M-53.27%
Dec 31, 2022618.97M-373.62M-37.64%
Dec 31, 2021992.58M570.87M135.37%
Dec 31, 2020421.71M389.18M1,196.46%
Dec 31, 201932.53M11.18M52.35%
Dec 31, 201821.35M2.62M13.99%
Dec 31, 201718.73M454.00K2.48%
Dec 31, 201618.28M8.70M90.85%
Dec 31, 20159.58M8.30M649.30%
Dec 31, 20141.28M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition